| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 51.495 | 53.440 | 54.110 | 64.076 | 69.978 | 98.092 | 104.305 | 100.339 | 117.421 | 147.902 |
| Total Income - EUR | 51.496 | 53.440 | 54.111 | 65.473 | 70.039 | 98.128 | 104.307 | 100.341 | 117.424 | 148.615 |
| Total Expenses - EUR | 47.200 | 43.024 | 39.157 | 24.346 | 49.736 | 76.041 | 72.064 | 90.399 | 112.072 | 110.382 |
| Gross Profit/Loss - EUR | 4.296 | 10.416 | 14.954 | 41.127 | 20.303 | 22.087 | 32.243 | 9.941 | 5.352 | 38.233 |
| Net Profit/Loss - EUR | 2.751 | 9.882 | 14.398 | 40.486 | 19.602 | 21.124 | 31.218 | 9.088 | 4.236 | 33.997 |
| Employees | 2 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Santomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.495 | 2.757 | 2.710 | 7.940 | 25.559 | 15.786 | 11.184 | 6.955 | 2.682 | 2.300 |
| Current Assets | 4.001 | 4.066 | 11.324 | 28.828 | 46.636 | 16.005 | 50.416 | 64.718 | 55.562 | 69.950 |
| Inventories | 795 | 787 | 774 | 760 | 745 | 731 | 715 | 717 | 715 | 711 |
| Receivables | 1.835 | 2.183 | 2.675 | 6.254 | 2.072 | 332 | 6.392 | 4.853 | 5.672 | 3.311 |
| Cash | 1.371 | 1.096 | 7.875 | 21.814 | 43.819 | 14.942 | 43.310 | 59.148 | 49.174 | 65.928 |
| Shareholders Funds | 2.796 | 4.708 | 9.312 | 35.493 | 54.408 | 27.986 | 58.583 | 67.853 | 40.548 | 59.241 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.701 | 2.114 | 4.721 | 1.275 | 17.786 | 3.805 | 3.018 | 3.820 | 17.696 | 13.008 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8512 - 8512" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Santomed S.r.l.